RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Yield10 Bioscience Stock

Yield10 Bioscience EBIT 2024

Yield10 Bioscience EBIT

-9.59 M USD

Ticker

YTEN

ISIN

US98585K8624

WKN

A2PYHH

In 2024, Yield10 Bioscience's EBIT was -9.59 M USD, a -33.51% increase from the -14.42 M USD EBIT recorded in the previous year.

The Yield10 Bioscience EBIT history

YEAREBIT (undefined USD)
2029e-
2028e14.47
2027e3.16
2026e-6.28
2025e-10.13
2024e-9.59
2023-14.42
2022-13.45
2021-11.55
2020-9.61
2019-8.59
2018-9.32
2017-9.28
2016-10.25
2015-12.47
2014-26.83
2013-28.54
20123.93
2011-38.86
2010-38.94
2009-38.73
2008-38.89
2007-33.82
2006-17.52
2005-7.02
2004-5

Yield10 Bioscience Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Yield10 Bioscience, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Yield10 Bioscience from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Yield10 Bioscience’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Yield10 Bioscience. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Yield10 Bioscience’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Yield10 Bioscience’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Yield10 Bioscience’s growth potential.

Yield10 Bioscience Revenue, EBIT and net profit per share

DateYield10 Bioscience RevenueYield10 Bioscience EBITYield10 Bioscience Net Income
2029e91.1 M undefined0 undefined235,007.99 undefined
2028e72.14 M undefined14.47 M undefined143,615.99 undefined
2027e48.09 M undefined3.16 M undefined32,640 undefined
2026e27.29 M undefined-6.28 M undefined-91,392 undefined
2025e1.22 M undefined-10.13 M undefined-1.8 M undefined
2024e1.22 M undefined-9.59 M undefined-7.04 M undefined
202360,000 undefined-14.42 M undefined-14.46 M undefined
2022450,000 undefined-13.45 M undefined-13.57 M undefined
2021610,000 undefined-11.55 M undefined-11.03 M undefined
2020800,000 undefined-9.61 M undefined-10.21 M undefined
2019810,000 undefined-8.59 M undefined-12.96 M undefined
2018560,000 undefined-9.32 M undefined-9.19 M undefined
2017940,000 undefined-9.28 M undefined-10.82 M undefined
20161.16 M undefined-10.25 M undefined-7.6 M undefined
20151.35 M undefined-12.47 M undefined-23.68 M undefined
20142.8 M undefined-26.83 M undefined-29.53 M undefined
20133.78 M undefined-28.54 M undefined-30.51 M undefined
201241.38 M undefined3.93 M undefined3.63 M undefined
20111.43 M undefined-38.86 M undefined-38.79 M undefined
2010450,000 undefined-38.94 M undefined-38.8 M undefined
20091.43 M undefined-38.73 M undefined-37.96 M undefined
20081.56 M undefined-38.89 M undefined-36.01 M undefined
20071.68 M undefined-33.82 M undefined-27.88 M undefined
20064.59 M undefined-17.52 M undefined-16.06 M undefined
20052.78 M undefined-7.02 M undefined-7.63 M undefined
20043.68 M undefined-5 M undefined-5.06 M undefined

Yield10 Bioscience stock margins

The Yield10 Bioscience margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Yield10 Bioscience. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Yield10 Bioscience.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Yield10 Bioscience's sales revenue. A higher gross margin percentage indicates that the Yield10 Bioscience retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Yield10 Bioscience's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Yield10 Bioscience's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Yield10 Bioscience's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Yield10 Bioscience. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Yield10 Bioscience's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Yield10 Bioscience Margin History

Yield10 Bioscience Gross marginYield10 Bioscience Profit marginYield10 Bioscience EBIT marginYield10 Bioscience Profit margin
2029e47.14 %0 %0.26 %
2028e47.14 %20.05 %0.2 %
2027e47.14 %6.57 %0.07 %
2026e47.14 %-23.01 %-0.33 %
2025e47.14 %-827.58 %-147.2 %
2024e47.14 %-783.17 %-574.93 %
202347.14 %-24,028.33 %-24,091.67 %
202247.14 %-2,988.89 %-3,015.56 %
202147.14 %-1,893.44 %-1,808.2 %
202047.14 %-1,201.25 %-1,276.25 %
201947.14 %-1,060.49 %-1,600 %
201847.14 %-1,664.29 %-1,641.07 %
201747.14 %-987.23 %-1,151.06 %
201647.14 %-883.62 %-655.17 %
201547.14 %-923.7 %-1,754.07 %
201447.14 %-958.21 %-1,054.64 %
201349.47 %-755.03 %-807.14 %
201297.51 %9.5 %8.77 %
2011100 %-2,717.48 %-2,712.59 %
2010-5,162.22 %-8,653.33 %-8,622.22 %
2009-1,611.89 %-2,708.39 %-2,654.55 %
2008-1,481.41 %-2,492.95 %-2,308.33 %
2007-1,084.52 %-2,013.1 %-1,659.52 %
2006-144.88 %-381.7 %-349.89 %
2005-115.11 %-252.52 %-274.46 %
2004-47.55 %-135.87 %-137.5 %

Yield10 Bioscience Aktienanalyse

What does Yield10 Bioscience do?

Yield10 Bioscience ist eines der beliebtesten Unternehmen auf Eulerpool.com.

EBIT Details

Analyzing Yield10 Bioscience's EBIT

Yield10 Bioscience's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Yield10 Bioscience's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Yield10 Bioscience's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Yield10 Bioscience’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Yield10 Bioscience stock

How much did Yield10 Bioscience achieve in EBIT for the current year?

In the current year, Yield10 Bioscience has achieved an EBIT of -9.59 M USD.

What is EBIT?

EBIT stands for Earnings Before Interest and Taxes and refers to the profit before interest and taxes of a company Yield10 Bioscience.

How has the EBIT of Yield10 Bioscience developed in recent years?

The EBIT of Yield10 Bioscience has increased by -33.509% decreased compared to the previous year.

What does EBIT mean for investors?

EBIT provides investors with insights into a company's profitability as it reflects the profit before interest expenses and taxes.

Why is EBIT an important indicator for investors?

Since EBIT provides a more direct insight into a company's profit than net income, it is an important indicator for investors to assess the profitability of a company.

Why do EBIT values fluctuate?

EBIT values can fluctuate as they are influenced by various factors, such as revenue, costs, and tax effects.

What role does tax burden play in EBIT?

Tax burdens have a direct impact on a company's EBIT, as they are deducted from the profit.

How is EBIT presented in the balance sheet of the company Yield10 Bioscience?

The EBIT of Yield10 Bioscience is listed in the income statement.

Can EBIT be used as a single indicator for evaluating a company?

EBIT is an important indicator for evaluating a company, but additional financial ratios should also be considered to get a comprehensive picture.

Why is EBIT not equal to net profit?

The net profit of a company includes taxes and interest, while EBIT represents the profit before interest and taxes.

How much dividend does Yield10 Bioscience pay?

Over the past 12 months, Yield10 Bioscience paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Yield10 Bioscience is expected to pay a dividend of 0 USD.

What is the dividend yield of Yield10 Bioscience?

The current dividend yield of Yield10 Bioscience is .

When does Yield10 Bioscience pay dividends?

Yield10 Bioscience pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Yield10 Bioscience?

Yield10 Bioscience paid dividends every year for the past 0 years.

What is the dividend of Yield10 Bioscience?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Yield10 Bioscience located?

Yield10 Bioscience is assigned to the 'Health' sector.

Wann musste ich die Aktien von Yield10 Bioscience kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Yield10 Bioscience from 11/1/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/1/2024.

When did Yield10 Bioscience pay the last dividend?

The last dividend was paid out on 11/1/2024.

What was the dividend of Yield10 Bioscience in the year 2023?

In the year 2023, Yield10 Bioscience distributed 0 USD as dividends.

In which currency does Yield10 Bioscience pay out the dividend?

The dividends of Yield10 Bioscience are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Yield10 Bioscience stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Yield10 Bioscience

Our stock analysis for Yield10 Bioscience Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Yield10 Bioscience Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.